Clinical Trial Search

Primary: Comparison of Postoperative Nausea and Vomiting Scores Between Groups Treated With a ReletexTM Device and Those Without the Device. — 1.81; 2.03 units on a scale

Primary: Number of Participants With PONV-related Delay of Hospital Discharge — 0; 4 Participants

Primary: Number of Participants With Nausea and/or Vomiting — 10; 26 Participants — p=0.003

Primary: Post-operative Nausea and Vomiting

Primary: Postoperative Vomiting — 11; 9; 66; 68 participants — p=0.05

Primary: PONV During the First 24 Hours After Bariatric Surgery — 22; 12 participants — p=0.04

Primary: Adherence to PONV Guidelines — 666; 5260; 5863 Participants

Primary: Overall Complete Response Rate — 10; 10 percentage of participants

Primary: PONV Incidence — 12 participants

Primary: Number of Participants With Nausea 1 Hour After Post-anesthesia Care Unit (PACU) Admission — 1; 0; 1; 14 Participants

Primary: Average Daily Use of Rescue Medications for Exacerbation of Nausea/Vomiting. — 1.186; 0.551; 0.754; 0.447 medications/day

Primary: Number of Participants With Nausea and Vomiting — 24; 29 participants

Primary: Episodes of Postoperative Nausea — 0; 16 episodes

Primary: Incidence of Nausea — 46; 54 percentage of participants

Primary: Proportion of Patients With a Complete Response/Complete Control During the First 24 Hours After Neurological Surgery Under General Anesthesia — 38; 41; 30; 30…

Primary: Number of Participants With Acute Nausea and Vomiting — 101 Participants

Primary: Post-operative Nausea — 24; 70 percentage of subjects with PON

Primary: Incidence of Postoperative Nausea and Vomiting — 34.4; 29.8; 12.5; 7 percentage of participants — p=>0.76

Primary: Postoperative Pain — 3; 2; 2; 3 score on a scale

Primary: Comparison of PONV Score of Assessments Done at 15 Minutes After Arrival in PACU Using 11-point Nausea Scale (nVRS) — 35; 33; 1; 2 Participants

Primary: The Incidence of Postoperative Nausea and Vomiting — 5; 18 Participants — p=<0.05

Primary: Number of Participants With Postoperative Nausea and Vomiting — 28; 34 participants

Primary: Number of Participants Achieving at Least a 50% Improvement in the Gastroesophageal Reflux Disease Health-related Quality of Life Index (GERD-HRQL) From Baseline to 12…

Primary: Post-operative Nausea Scores — NA; NA; NA; NA participants

Primary: Mean Plasma Glucose Area Under the Curve (AUC 0-3h) — 22,192.5; 25,207.1; 21,715.9 mg*min/dl

Primary: a) Number of Participants With High Pain Levels (Using the Visual Analog Scale) — 31; 3 Participants

Primary: Number of Participants Presenting Reflux Symptoms — 31; 8; 5 participants — p=<0.001

Primary: Number of Participants Having Post-operative Emesis and Nausea. — 7; 22 participants — p=<0.05

Primary: Number of Participants With Improvement in Nausea — 29; 25 participants — p=0.43

Primary: Evaluate the Amount of Diluadid Given Postoperatively — 11.035; 8.7; 12.4 ml